Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

Dec-21

Endocrinology Gynecology and Obstetrics Women's Health

AUTHORS : Prof Wiebke Arlt, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK – Email: w.arlt@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/metabolism-systems/arlt-wiebke.aspx OR Dr Krishnarajah Nirantharakumar, Institute of Applied Health Research, IOEM Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK – Email: k.nirantharan@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/nirantharakumar-krishnarajah.aspx

JOURNAL : Diabetes Care

REFERENCE: 44(12):2758-2766

DOI : 10.2337/dc21-0437

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

More publications

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis

Using repeated measurements to predict cardiovascular risk in patients with type 2 diabetes Mellitus

Exposure to Domestic Abuse and the Subsequent Development of Atopic Disease in Women